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Purpose: To identify the factors affecting the surgical decisions of experienced physicians when treating patients with lower 
urinary tract symptoms that are suggestive of benign prostatic hyperplasia (LUTS/BPH).
Methods: Patients with LUTS/BPH treated by two physicians between October 2004 and August 2013 were included in this 
study. The causal Bayesian network (CBN) model was used to analyze factors influencing the surgical decisions of physicians 
and the actual performance of surgery. The accuracies of the established CBN models were verified using linear regression (LR) 
analysis. 
Results: A total of 1,108 patients with LUTS/BPH were analyzed. The mean age and total prostate volume (TPV) were 66.2 
(±7.3, standard deviation) years and 47.3 (±25.4) mL, respectively. Of the total 1,108 patients, 603 (54.4%) were treated by 
physician A and 505 (45.6%) were treated by physician B. Although surgery was recommended to 699 patients (63.1%), 589 
(53.2%) actually underwent surgery. Our CBN model showed that the TPV (R=0.432), treating physician (R=0.370), bladder 
outlet obstruction (BOO) on urodynamic study (UDS) (R=0.324), and International Prostate Symptom Score (IPSS) ques-
tion 3 (intermittency; R =0.141) were the factors directly influencing the surgical decision. The transition zone volume 
(R=0.396), treating physician (R=0.340), and BOO (R=0.300) directly affected the performance of surgery. Compared to the 
LR model, the area under the receiver operating characteristic curve of the CBN surgical decision model was slightly compro-
mised (0.803 vs. 0.847, P<0.001), whereas that of the actual performance of surgery model was similar (0.801 vs. 0.820, 
P=0.063) to the LR model.
Conclusions: The TPV, treating physician, BOO on UDS, and the IPSS item of intermittency were factors that directly influ-
enced decision-making in physicians treating patients with LUTS/BPH. 
Keywords: Bayes Theorem; Decision Support Techniques; Decision Making, Computer-Assisted; Prostatic Hyperplasia; Uro-
dynamics
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INTRODUCTION
Recent international guidelines on lower urinary tract symp-
toms that are suggestive of benign prostatic hyperplasia (LUTS/
BPH) recommend that surgery is indicated when complications 
are present [1,2]. However, most patients with LUTS/BPH are 
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not absolutely indicated for surgery [3]. Hence, the physician 
must decide the best initial treatment (including whether to per-
form surgery) on a case-by-case basis according to clinical con-
ditions. 
 For that decision, numerous clinical parameters must be con-
sidered, such as: LUTS type and severity; voiding pattern identi-
fied by a bladder diary; response to oral medication; prostate 
size; and uroflowmetry (UFM) parameters, including postvoid 
residual (PVR), endoscopic findings, or urodynamic study 
(UDS) results [1,2]. The decision is also influenced by patient-
related factors, such as age, patient preference, willingness to ac-
cept surgery-associated complications (e.g., retrograde ejacula-
tion), comorbidities, current medications (such as anticoagu-
lants), socioeconomic status, medical insurance, personal sched-
ule, and geographic accessibility to a clinic [1,2]. 
 The analysis of the clinical decisions made by experienced 
physicians in the management of LUTS/BPH is important be-
cause the related factors related to the decision made can be in-
tegrated, and can thus provide a new level of evidence for the 
rational management of LUTS/BPH [4]. However, few studies 
have investigated LUTS/BPH management decisions [5]. Since 
many factors require consideration, some of which have covari-
ability (interaction between parameters) [6], the associations 
between influencing factors and surgical decisions are complex 
and largely unclear. To overcome these problems, the causal 
Bayesian network (CBN) model has emerged as a more ad-
vanced alternative to conventional statistical models in the 
medical field [7]. The benefit of this model is that it can be used 
to visualize the interaction of cause-effect relationships and can 
eliminate indirect causes of events [8]. Therefore, this novel 
model is suitable for analyzing clinical decisions and establish-
ing a clinical decision support system in the medical field [9]. 
 We hypothesized that the CBN model can analyze the surgi-
cal decisions of physicians for patients with LUTS/BPH and can 
determine some direct causes of the decisions without compro-
mised predictive values. In the present study, we aimed to iden-
tify the factors directly influencing the surgical decisions of ex-
perienced physicians and the actual performance of the surgery 
using the CBN model. 
MATERIALS AND METHODS
The Institutional Review Board of Seoul National University 
Hospital (SNUH) approved the present study (No. H 1106-066-
366). The inclusion criteria were male patients with LUTS/BPH 
and age of ≥45 years. Patients with a history of genitourinary 
surgery, genitourinary malignancy, pelvic radiation therapy, cur-
rent urinary tract infection (UTI), urethral stricture, interstitial 
cystitis, neuropathy suggestive of neurogenic bladder, and in-
complete evaluations were excluded from the analysis. Among 
them, patients who were absolutely indicated for surgery by the 
international treatment guidelines [1,2], including those with re-
fractory retention, recurrent gross hematuria, bladder stone, re-
current UTI, or renal insufficiency, were also excluded, as our 
intent was to analyze patients with LUTS/BPH who had only 
relative indicators for surgery.
 The following UDS results and clinical parameters were col-
lected from our institution’s Urodynamic Database Registry and 
Electronic Medical Records system: history, physical examina-
tion, International Prostate Symptom Score (IPSS) [10], UFM 
parameters (including PVR), prostate-specific antigen (PSA) 
level, and prostate size as measured by transrectal ultrasonogra-
phy. Moreover, whether the physician recommended the sur-
gery and whether the operation was actually performed were 
also reviewed. If the decision to perform surgery and actual 
performance of surgery differed, the reason was identified. All 
UDS (UD-2000, Medical Measurement Systems B.V., En-
schede, the Netherlands) were performed according to the rec-
ommendations of the International Continence Society [11,12]. 
The bladder outlet obstruction (BOO) index was defined as de-
trusor pressure at the maximal flow rate (PdetQmax) – 2 × 
maximum flow rate (Qmax), and the presence of BOO was de-
fined by a BOO index of ≥40 [13].
 Fig. 1 shows a simple CBN model. In that model, events A 
and D are in the causal Markov condition [14]. Since event D is 
not directly influenced by event A, the conditions of events B 
and C directly affect event D, whereas information about event 
A is not needed. The causal Markov condition can be visually 
Fig. 1. A simple causal Bayesian network model that can visual-
ize the causal Markov conditions in male patients with lower uri-
nary tract symptoms.
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identified in the CBN, which has a relationship of two or more 
degrees between nodes. In Fig. 1, events B and C are in a first-
degree relationship with event D, meaning that events B and C 
are factors directly influencing event D. The probability of event 
D occurring can be expressed as P (event D|event B, event C). The 
joint probability of multiple events (X1, X2, …, Xn) in specific sit-
uations (K) can be calculated as follows:
where πi indicates a joint state of the parents of Xi, and K de-
notes background knowledge [8].
 The CBN model was used to analyze the decision of physi-
cians to perform surgery in patients with relative indications for 
the surgery. The clinical parameters considered to be causal fac-
tors contributing to the performance of surgery include the 
treating physician (two physicians masked as A and B), age, 
Qmax, PVR, PSA level, total prostate volume (TPV), transition 
zone volume (TZV), BOO on UDS, and IPSS (each individual 
score for questions 1 to 7, quality of life question [IPSS-QoL], 
emptying sum score [IPSS-emptying, sum of questions 1, 3, 5, 
and 6], storage sum score [IPSS-storage, sum of questions 2, 4, 
and 7], and total sum score [IPSS-total, sum of questions 1 to 7]). 
All causative variables were categorized into three groups by dis-
tribution (cutoff points: mean±1/2 × standard deviation [SD]). 
Other patient-related factors (e.g., comorbidity, socioeconomic 
status) were excluded from the analysis. In the CBN models, 
nodes showing a first-degree relationship with surgical decision-
making were identified as directly influencing factors. Other 
nodes were considered to have a causal Markov condition. The 
directional nature of each tie was ignored. The weight of each 
directly influencing factor was estimated using the Spearman’s 
correlation test.
 Two CBN models were established to identify the direct 
cause(s) of two major events: (1) the surgical decision of the 
physician (surgical decision-CBN model); and (2) the actual 
performance of LUTS/BPH surgery (actual operation-CBN 
model). For the surgical decision-CBN model, the aforemen-
tioned causative factors and whether the physician recom-
mended surgery were evaluated. In the actual operation-CBN 
model, causative factors and whether the operation was actually 
performed were evaluated. 
 The accuracy of these two models was verified by the predic-
tive values obtained on a backward stepwise linear regression 
(LR) analysis [15]. The CBN models were established using Ban-
jo ver. 2.2.0 (Duke University, Durham, NC, USA). The mode of 
the CBN models was a high-scoring network that limited the 
number of parents to five and ran the analysis for up to 6 hours. 
To compare accuracy, the comparison of the receiver operating 
characteristic (ROC) curves described by DeLong et al. [16] was 
applied using Medcalc ver. 12.4.0 (MedCalc Software, Ostend, 
Belgium). Other descriptive statistics were processed using 
PASW Statistics ver. 18.0 (SPSS Inc., Chicago, IL, USA). Values 
with P<0.05 were considered significant. 
RESULTS
From October 2004 to August 2013, a total of 2,492 patients aged 
≥45 years with LUTS/BPH were identified from among 10,184 
cases in the SNUH Urodynamic Database Registry. Among 
them, 1,299 patients were treated by two physicians (S.J.O. and 
J.S.P.). Of the 1,299 patients, 120 (9.3%) were excluded according 
to the exclusion criteria mentioned above; thus, 1,179 subjects 
remained. Among them, 71 (6.0%) were absolutely indicated for 
surgery [1,2], and the remaining 1,108 patients with LUTS/BPH 
had relative indicators for surgery.
 The patient demographics are shown in Table 1. The mean 
age was 66.2 ( ±7.3, SD) years. The TPV and PSA were 47.3 
(±25.4) mL and 2.47 (±3.19) ng/mL, respectively. IPSS-total 
and IPSS-QoL scores were 18.0 (±7.8) and 4.0 (±1.2), respec-
tively. The mean BOO index was 33.8 (±24.5), and 331 patients 
(29.9%) were classified as having BOO. Of the 1,108 patients, 
603 (54.4%) were treated by physician A and 505 (45.6%) were 
treated by physician B. Although surgery was recommended 
for 699 patients (63.1%), 589 (53.2%) actually underwent sur-
gery. Details of the differences between surgical decisions and 
performed surgeries are shown in Table 1.
Which Parameters Influenced the Surgical Decision? 
(Surgical Decision Model)
The best CBN structure for the surgical decision-CBN model is 
shown in Fig. 2. The treating physician, TPV, response to IPSS 
question 3 (intermittency), and BOO on UDS had first-degree 
relationships with the physician’s decision. Therefore, those four 
factors were selected as the factors directly influencing the physi-
cians’ surgical decisions. The correlation coefficient was the high-
est for TPV (R=0.432, P<0.001), followed by treating physician 
(R=0.370, P<0.001), BOO on UDS (R=0.324, P<0.001), and 
response to IPSS question 3 (R=0.141, P<0.001). The area under 
the receiver operating characteristic curve (AUROC) of the sur-
gical decision-CBN model was 0.803, which was compromised 
                                                                                  n
P (X1, X2, ..., Xn | K) = π P (Xi | πi, K)
                                                                              i =1
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compared to that of the LR models with the same parameters 
(surgical decision-LR model; P<0.001) (Fig. 3A). The results of 
the surgical decision-LR model are shown in Table 2.
Fig. 2. A causal Bayesian network model for surgical decisions 
(Surgical Decision-CBN Model), which indicates the parameters 
that directly influenced the physician’s surgical decision. The 
CBN models were established using Banjo ver. 2.2.0 (Duke Uni-
versity, Durham, NC, USA). IPSS, International Prostate Symp-
tom Score; IPSS-total, sum of questions 1 to 7; IPSS-emptying, 
sum of questions 1, 3, 5 and 6; IPSS-storage, sum of questions 2, 
4, and 7; IPSS-QoL, quality of life question score; BOO_ICS_no-
mogram, bladder outlet obstruction index; TPV, total prostate 
volume; TZV, transition zone volume; PSA, prostate-specific an-
tigen; FreeQmax, maximum flow rate on uroflowmetry; 
FreePVR, postvoid residual.
IPSS_2
IPSS_total
IPSS_storage
IPSS_emptying
IPSS_7 IPSS_QoL IPSS_4
IPSS_5 IPSS_3 IPSS_6
IPSS_1 Physician_decision
Physician
BOO_ICS_nomogram
FreeQmax FreePVR
TPV
PSA TZV
Age
Table 1. Characteristics of the 1,108 included patients
Characteristic Value
Age (yr) 65.9±7.2
Prostate volume (mL)
   Total prostate volume 47.3±25.4
   Transition zone volume 22.8±18.7
Prostate-specific antigen (ng/mL) 2.47±3.19
International Prostatic Symptom Score (IPSS)
   IPSS-total 18.0±7.8
   IPSS-emptying 10.9±5.5
   IPSS-storage 7.1±3.5
   IPSS-quality of life 4.0±1.2
Uroflowmetry parameters
   Maximum flow rate (mL/sec) 11.7±4.9
   Postvoid residual volume (mL) 55.7±76.7
Urodynamic study parameters
   Maximal urethral closure pressure (cm H2O) 75.0±26.4
   Functional urethral length (mm) 71.8±21.7
   First desire (mL) 199.9±89.7
   Normal desire (mL) 283.9±108.0
   Strong desire (mL) 374.3±108.9
   Compliance (mL/cm H2O)   65.9±49.9
   PdetQmax (cm H2O) 51.4±21.0
   Opening pressure (cm H2O) 52.2±24.9
   Bladder outlet obstruction index 33.8±24.5
Treated by 
   Physician A 603 (54.4)
   Physician B 505 (45.6)
Recommended to do surgery 699 (63.1)
Actually received surgery 589 (53.2)
   Transurethral prostatectomy 8 (0.7)
   Open prostatectomy 3 (0.3)
   Holmium laser enucleation of the prostate 402 (36.3)
   Photoselective vaporization of prostate 158 (14.3)
   Transurethral incision 13 (1.2)
Details in the difference between the surgical 
   decision and actual operation
   Not recommended surgery but received 3 (
      Do not want oral medication 3 (100)
   Recommended surgery but not received 113 (
      Underlying risks for anesthesia 6 (5.3)
      Economic problem 2 (1.8)
      Fear for operation (pain, complication, etc.) 37 (32.7)
      Personal problem (other plan, etc.) 13 (11.5)
      WeIl-controlled by oral medication 43 (38.1)
      Unidetified reasons 12 (10.6)
Values are presented as mean±standard deviation or number (%).
IPSS-total, sum of questions 1 to 7; IPSS-emptying, sum of questions 1, 3, 
5 and 6; IPSS-storage, sum of questions 2, 4, and 7; IPSS-QoL, quality of 
life question score; PdetQmax, detrusor pressure at maximum flow rate.
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Parameters Directly Affecting Actual Performance of 
Surgery (Actual Surgery Model)
Fig. 4 shows the best CBN structure for the actual surgery-CBN 
model. The treating physician, TZV, and BOO on UDS showed a 
first-degree relationship with the actual surgery. Therefore, those 
three factors were selected as the factors directly influencing ac-
tual surgery. The correlation coefficient was the highest for TZV 
(R=0.396, P<0.001), followed by treating physician (R=0.340, 
P<0.001) and BOO on UDS (R=0.300, P<0.001). The AUROC 
of the actual surgery-CBN model was 0.801, which was not sta-
tistically different from that of the actual surgery-LR model with 
the same parameters (P=0.063) (Fig. 3B). The results of the actu-
al surgery-LR model are shown in Table 2.
DISCUSSION
Although a large number of studies have been published over 
several decades, there is very often insufficient evidence based 
on which clear statements about “the right treatment for every 
patient” can be made [4]. Moreover, changes in other modalities, 
such as oral medication, can cause changes in trends for the sur-
Fig. 3. Comparison of receiver operating characteristic (ROC) 
curves between the causal Bayesian network (CBN) models and lin-
ear regression (LR) models. (A) Surgical decision model (n=1,108). 
Area under the ROC curve: surgical decision-CBN model, 0.803 
(95% confidence interval [CI], 0.779–0.826); surgical decision-LR 
model, 0.847 (95% CI, 0.824–0.868). Pairwise comparison of ROC 
curves: Difference between areas, 0.0438 (P<0.001; 95% CI, 0.0192–
0.0683). (B) Actual surgery model (n=1,108). Area under the ROC 
curve: actual surgery-CBN model, 0.801 (95% CI, 0.777–0.824); ac-
tual surgery-LR model, 0.820 (95% CI, 0.796–0.842). Pairwise com-
parison of the ROC curves: Difference between areas: 0.0184 
(P=0.063; 95% CI, –0.001 to 0.038).
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Fig. 4. A causal Bayesian network model for actual performance 
of surgery (actual surgery-CBN model), which indicates the pa-
rameters that directly affected actual surgical performance. IPSS, 
International Prostate Symptom Score; IPSS-total, sum of ques-
tion 1 to 7; IPSS-emptying, sum of questions 1, 3, 5 and 6; IPSS-
storage, sum of questions 2, 4, and 7; IPSS-QoL, quality of life 
question score; BOO_ICS_nomogram, bladder outlet obstruc-
tion index; TPV, total prostate volume; TZV, transition zone vol-
ume; PSA, prostate-specific antigen; FreeQmax, maximum flow 
rate on uroflowmetry; FreePVR, postvoid residual.
FreeQmax
BOO_ICS_nomogramPhysician
IPSS_2 Operation_YN FreePVR
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TPV Age
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gical treatment of LUTS/BPH [17]. The treatment outcomes de-
pend on the success standard. For instance, there has been con-
troversy over the usefulness of UDS in preoperative LUTS/BPH 
evaluation. However, Javle et al. [18] reported that treatment 
failure occurred in 100% of patients in a urodynamically unob-
structed subgroup after transurethral prostatectomy (TURP); 
therefore, UDS is helpful for ruling out a subgroup of patients 
who would not benefit. On the other hand, Gotoh et al. [19] re-
ported that patients with minimal urodynamic obstruction also 
have a good outcome; therefore, such patients should not neces-
sarily be considered contraindicated for surgery. However, those 
two studies had different definitions of treatment success—the 
former strictly defined success as 50% improvement in IPSS, 
Qmax, and PVR [19], whereas the latter defined it as fair, good, 
or excellent on a subjective satisfaction scale (full scale: poor/
fair/good/excellent) [19]. It is already known that UFM parame-
ters and voiding symptoms are not well correlated [20]. 
Table 2. Multiple linear regression (LR) models with the same parameters as the causal Bayesian network models (only the parame-
ters enrolled within the models are presented)
Unstandardized coefficients Standardized coefficients
t P-value
Collinearity statistics
B SE β Tolerance VIF
Surgical decision-LR model (n=1,108)
   (Constant) –0.408 0.137 –2.986 0.003
   Age 0.005 0.002 0.073 2.796 0.005 0.899 1.113
   Qmax –0.013 0.003 –0.132 –5.005 <0.001 0.891 1.123
   TPV 0.004 0.001 0.227 8.294 <0.001 0.824 1.214
   IPSS Q5 0.030 0.008 0.100 3.630 <0.001 0.806 1.240
   IPSS Q7 –0.025 0.010 –0.066 –2.438 0.015 0.833 1.201
   IPSS Q8 0.022 0.012 0.054 1.886 0.060 0.739 1.353
   BOO on UDS 0.203 0.029 0.193 6.971 <0.001 0.807 1.239
   Physician (B) 0.323 0.024 0.333 13.258 <0.001 0.975 1.025
Actual surgery-LR model (n=1,108)
   (Constant) –0.563 0.145 –3.889 <0.001
   Age 0.005 0.002 0.071 2.628 0.009 0.899 1.113
   Qmax –0.012 0.003 –0.114 –4.241 <0.001 0.891 1.123
   TPV 0.005 0.001 0.235 8.374 <0.001 0.824 1.214
   IPSS Q5 0.027 0.009 0.086 3.032 0.002 0.806 1.240
   IPSS Q7 –0.026 0.011 –0.067 –2.411 0.016 0.833 1.201
   IPSS Q8 0.041 0.013 0.096 3.239 0.001 0.739 1.353
   BOO on UDS 0.187 0.031 0.172 6.070 <0.001 0.807 1.239
   Physician (B) 0.305 0.026 0.304 11.800 <0.001 0.975 1.025
SE, standard error; t, T score; VIF, variance inflation factor; Qmax, maximum flow rate on uroflowmetry, TPV; total prostate volume; IPSS, Interna-
tional Prostate Symptom Score; BOO, bladder outlet obstruction; UDS, urodynamic study.
 The large numbers of published studies providing conflicting 
evidence as well as numerous other issues surrounding the ac-
ceptance of such evidence become barriers to using research evi-
dence in daily practice [21]. However, analyzing the logic of ex-
perts can provide a new level of evidence for the rational man-
agement of LUTS/BPH [4]. Our CBN results demonstrated that 
TPV (R=0.432), treating physician (R=0.370), BOO on UDS 
(R=0.324), and response to IPSS question 3 (R=0.141) directly 
influenced the surgical decision for patients with LUTS/BPH 
(Fig. 2). Seki et al. [22] studied the prognostic factors for out-
comes after TURP and concluded that Schäfer’s grade (grade of 
urodynamic obstruction [23]) and detrusor overactivity in UDS 
were related to outcomes. However, prostate volume, which was 
an important surgical decision-making factor in the present 
study, was not considered in the model of Seki et al. [22]. The 
consideration of all proven decision-making factors in a prog-
nostic model is assumed to be more rational. 
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 It is interesting that response to IPSS question 3 can represent 
all other IPSS domains as a factor directly influencing physi-
cians’ surgical decisions (Fig. 2). Our surgical decision-CBN 
model (Fig. 2) demonstrated that all domains of the IPSS are 
clustered and that they converge on IPSS question 3. These find-
ings suggest that each IPSS domain had covariability and did not 
independently affect the surgical decision. This relationship en-
abled the ruling out of other IPSS domains as influencing factors 
on surgical decisions. In the actual surgery-CBN model, similar 
factors (TZV [R=0.396], physician [R=0.340], and BOO on 
UDS [R=0.300]) except for response to IPSS question 3 affected 
the actual performance of surgery (Fig. 4), although there were 
some discrepancies between the surgical decision and actual 
performance of surgery (116 of 1,108 patients [10.5%]; Table 1). 
However, the patient-related factors, such as patient’s preference, 
willingness to accept complications, comorbidities, socioeco-
nomic status, or hospital accessibility, were not fully considered 
in this model due to the lack of information. 
 The predictive performance of our surgical decision-CBN 
model is slightly compromised compared to that of the surgical 
decision-LR model (AUROC =0.803 vs. 0.847, respectively; 
P<0.001) (Fig. 3A). A counterbalance of the cause-and-effect 
relationships arising from various logical processes of the physi-
cians’ clinical decisions was postulated as the cause of those find-
ings. When the surgical decision was analyzed for each physi-
cian separately, the directly influencing factors differed (physi-
cian A: TZV [R =0.482], BOO on UDS [R =0.469], PVR 
[R=0.242], and response to IPSS question 3 [R=0.141]; physi-
cian B: TZV [R=0.239]; figures not presented). The result that 
discrete models by individual physicians had equivalent predic-
tive performances to LR models support that deduction. When 
pursuing logic integration as a new level of evidence, such as in 
the trial of Stoevelaar et al. [4], the latent risk of the counterbal-
ance of cause-and-effect relationships between logics should be 
considered. Although the two physicians in the present study 
used different logic methods to make surgical decisions, they 
did not violate the statements regarding the relative surgical in-
dicators of LUTS/BPH (nonresponders to medical treatment or 
those who do not want medical therapy but request active treat-
ment) based on international recommendations [1,2]. 
 We did not analyze which patients treated under the specific 
logic of a physician had better treatment outcomes. We believe 
that a definitive analysis of the treatment outcomes of patients 
treated by the different logics is a very important subject of a fur-
ther study. Moreover, because our decision models are based on 
the experiences of only two physicians, the results may not be 
generalizable. However, it is important to note that the interac-
tion of cause-effect relationships impacting surgical decisions 
can be visualized using a CBN model. By selecting only the di-
rectly influencing factors, two models (surgical decision and ac-
tual surgery-CBN models) demonstrated moderate predictive 
performance (AUROC=0.803 and 0.801, respectively). Based 
on this information and some additional data, a well-formed 
clinical decision support system for LUTS/BPH can eventually 
be established, as in other medical fields [9]. However, the CBN 
model of this study has some limitations, as follows: indirect 
weighting of contributors; ignoring the directional natures of 
each tie due to the limitations of the cross-sectional database; 
and conversion of continuously valued clinical parameters to 
categorical values. Therefore, an improved model is needed.
 The CBN model can visualize the interaction of cause-effect 
relationships impacting physicians’ decisions for LUTS/BPH 
patients. Our CBN model shows that TPV, treating physician, 
BOO on UDS, and response to IPSS question 3 were factors di-
rectly influencing surgical decisions made by physicians regard-
ing patients with LUTS/BPH. Among these, TPV was the most 
important factor for surgical decisions.
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